{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:54:00Z","timestamp":1790146440820,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ygyno.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T21:36:09Z","timestamp":1426023369000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)"],"prefix":"10.1016","volume":"137","author":[{"given":"Michael L.","family":"Pearl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Tulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Golightly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.03.002_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0010","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","article-title":"A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer","volume":"309","author":"Bast","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0015","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2004.10.028","article-title":"Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?","volume":"22","author":"Gronlund","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jnci\/djh081","article-title":"Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)","volume":"96","author":"Rustin","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2006.07.027","article-title":"CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy","volume":"104","author":"Juretzka","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2010.07.025","article-title":"CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study","volume":"119","author":"van Altena","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2009.06.038","article-title":"Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer","volume":"115","author":"Zivanovic","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jnci\/djs203","article-title":"Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time","volume":"104","author":"Swisher","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Alix-Panabieres","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201303698","article-title":"Biology, detection, and clinical implications of circulating tumor cells","volume":"7","author":"Joosse","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2014.03.016","article-title":"Circulating and disseminated tumor cells in ovarian cancer: a systematic review","volume":"133","author":"Romero-Laorden","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2013.08.006","article-title":"Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients","volume":"131","author":"Liu","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0070","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ygyno.2011.05.028","article-title":"Circulating tumor cells predict progression free survival and overall survival in patients with relapsed\/recurrent advanced ovarian cancer","volume":"122","author":"Poveda","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0075","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0080","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.2007.13.6523","article-title":"Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse","volume":"26","author":"Pachmann","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ijc.24814","article-title":"Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients","volume":"126","author":"Lu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2008.12.007","article-title":"Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer","volume":"277","author":"Paris","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0100","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1002\/ijc.28561","article-title":"Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer","volume":"134","author":"Friedlander","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0105","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2014.06.013","article-title":"Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer","volume":"134","author":"Pearl","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ijc.23871","article-title":"Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells","volume":"124","author":"Kennedy","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1536867X0300300301","article-title":"Odds ratios and logistic regression: further examples of their use and interpretation","volume":"3","author":"Hailpern","year":"2003","journal-title":"Stata J."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0120","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0125","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","article-title":"Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition","volume":"339","author":"Yu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1083\/jcb.125.2.437","article-title":"Ep-CAM: a human epithelial antigen is a homophilic cell\u2013cell adhesion molecule","volume":"125","author":"Litvinov","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2353\/ajpath.2007.070152","article-title":"Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule","volume":"171","author":"Trzpis","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0140","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/cncr.24084","article-title":"The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study","volume":"115","author":"Zorn","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0145","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0150","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1023055600919","article-title":"Seprase complexes in cellular invasiveness","volume":"22","author":"Chen","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0155","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","article-title":"Clinical implications of fibroblast activation protein in patients with colon cancer","volume":"13","author":"Henry","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0160","doi-asserted-by":"crossref","first-page":"15280","DOI":"10.1074\/jbc.M114.568501","article-title":"Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-beta signaling","volume":"289","author":"Tulley","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0165","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1158\/0008-5472.CAN-06-1499","article-title":"Activation of EDTA-resistant gelatinases in malignant human tumors","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0170","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/IGC.0b013e3182691254","article-title":"Prognostic significance of rising serum CA-125 levels within the normal range in patients with epithelial ovarian, primary peritoneal, and tubal cancers, who, after initial treatment, had a complete clinical response","volume":"22","author":"Levy","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0175","series-title":"Sampling techniques","author":"Cochran","year":"1977"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10549-011-1373-x","article-title":"Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients","volume":"130","author":"Raimondi","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0185","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-09-2042","article-title":"Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial","volume":"16","author":"Riethdorf","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0190","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic spread is an early step in breast cancer","volume":"13","author":"Husemann","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2015.03.002_bb0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1023\/A:1010650405753","article-title":"Metastasis of cancer: a conceptual history from antiquity to the 1990s","volume":"19","author":"Weiss","year":"2000","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ygyno.2015.03.002_bb0200","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/44.7.1379","article-title":"CA 125 in ovarian cancer: advances and controversy","volume":"44","author":"Fritsche","year":"1998","journal-title":"Clin. Chem."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815006770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T13:53:51Z","timestamp":1598795631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815006770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0090825815006770"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}